Rybelsus (semaglutide)
Direct answer
What you need to know
Evidence strength: StrongRybelsus is semaglutide, a GLP-1 receptor agonist approved for type 2 diabetes and given as a daily tablet. Oral semaglutide for type 2 diabetes — the first tablet in the class, and the reason a GLP-1 pill was possible at all.
Key takeaways
- Molecule: semaglutide. Approved for: type 2 diabetes.
- Form: daily tablet. Prescription-only, like every product in this class.
- Same molecule as Wegovy and Ozempic, approved for a different use.
Important limitation: This page does not reproduce Rybelsus’s label. Side-effect rates, contraindications, dosing schedules and interactions belong to the prescribing information, and we link to the class-wide guides rather than paraphrasing a label.
Next action: The label for Rybelsus is published on DailyMed and is the authority on how it is taken. Separately, here is how Rybelsus is priced on each route.
Primary sources: DailyMed, U.S. National Library of Medicine, U.S. Food & Drug Administration
General education, not medical advice. This page does not publish dosing instructions.
At a glance
- Molecule
- semaglutide
- Approved for
- type 2 diabetes
- Form
- daily tablet
- Self-pay, direct from manufacturer
- Not published
- Prescription required
- Yes — as for every GLP-1 receptor agonist
What it costs
Price is one of the few things about Rybelsus that belongs to the molecule rather than to the brand. semaglutide is sold in more than one form, and which form is prescribed moves the figure before any seller does. Where Rybelsus sits against every semaglutide price we have verified is set out form by form, with each provider’s membership fee added to its medication price.
What this page deliberately leaves out
Side-effect rates, contraindications, dosing schedules, and drug interactions for Rybelsus are on its FDA-approved label, published on DailyMed. We are not going to reproduce them here from anywhere else, because a drug page that looks complete but was assembled second-hand is more dangerous than one that is visibly partial.
What we do cover, at the level of the class rather than the product:
- Side effects — what is common, what is serious, and the boxed warning.
- Dosing and titration — why doses start low and climb, and what happens at each step.
- How these medications work — the four mechanisms, and why they also explain the side effects.
Questions people ask about Rybelsus
Is Rybelsus a GLP-1?
Yes. Rybelsus is semaglutide, a GLP-1 receptor agonist, approved for type 2 diabetes and given as a daily tablet. "GLP-1" is the drug class; semaglutide is the molecule; Rybelsus is the brand name that molecule is sold under for this use.
Is Rybelsus the same as Wegovy and Ozempic?
They are the same molecule — semaglutide — approved for different uses. Rybelsus is approved for type 2 diabetes; Wegovy for chronic weight management, and Ozempic for type 2 diabetes. That difference is not pharmacological, but it decides how an insurer treats each one, which is usually the practical question hiding inside "which is better".
Do you need a prescription for Rybelsus?
Yes, in the United States, as for every GLP-1 receptor agonist. Anything sold as Rybelsus without a prescription is not Rybelsus, whatever the label says — and a product bought outside the prescribing chain carries none of the manufacturing verification the approved product does.
How much does Rybelsus cost?
The manufacturer does not publish a self-pay price for Rybelsus. Where a price is not published we say so rather than estimate one, so the total for this product depends on the route you take to it.
Before you act on anything here
- Rybelsus is prescription-only. Anything sold as Rybelsus without a prescription is not Rybelsus.
- Take dosing and administration from the label on your own prescription, not from this page or any other.
- Approval status and price are checked on the dates shown and both change — re-verify before relying on either.
Sources
Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.
- FDA-approved prescribing information (drug labels)DailyMed, U.S. National Library of MedicineSupports: The approved indication and dosage form for Rybelsus, and the labelled information this page deliberately does not reproduce.
- Drug approvals, labeling and safety communicationsU.S. Food & Drug AdministrationSupports: Approval status for Rybelsus, checkable in Drugs@FDA and the Orange Book.
This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.